The Lefkofsky Foundation’s Donation To Cancer-based Hospitals

The recent increase in the number of patients and population aging and growth in America has increased health care charges. Furthermore, a new JAMA publication analysis indicated that a slight reduction in annual expenditure caused a shift in disease prevalence while the frequency of accessing healthcare services was constant. This is normal in America since this analysis denoted the disease’s spending break down.

The analysis illustrated that different diseases have different factors causing the major increase. Diabetes portrayed the greatest yearly spending increase. This was due to population aging growth, price and utilization of pharmaceuticals and diabetes prevalence. Despite attempts to minimize the rise in health care spending, the outpatient’s annual spending for all diseases increased. This was attributed to shorter hospital stays that offered packed care in fewer days at higher charges. It further stated that preventing hospitalizations due to high prices of drugs least increased health care spending. This research is important in the future and is subject to improvement.

The American entrepreneur, Eric Lefkofsky, was born on September 2, 1969. Mr. Lefkofsky is the co-founder and chief executive officer of Tempus, the co-founder of Echo Global Logistics, Lightbank, Mediaocean, Inner Workings and the chairman and co-founder of Groupon. He graduated with a bachelor’s degree in Law from the University of Michigan. Lefkofsky started his career as a carpet seller and later purchased Brandon Apparel. He co-founded Satrbelly, an internet company in 1990 to deal in promotional products.

In 2006, Mr. Lefkofsky and his wife founded the Lefkofsky Foundation with the aim of aiding children-based, charitable, educational and scientific organizations. The Lefkofsky Foundation has donated millions of dollars to Tempus. Tempus, co-founded by Lefkofsky, assists healthcare professionals and doctors develop personalized, data-driven and real-time treatment decisions though patients’ genetic code analysis. It uses the analysis method and cutting-edge demonic sequencing while aiding doctor understanding on patient’s tumor. This is why it works on patients with lung, pancreatic and breast cancer. Notably, Tempus is motivated at caring for loved ones and cancer patients than money.

To know more click here